Establishing Clinical Significance in Rotator Cuff Disease
Establishing the Clinical Significance Values of Scales Used in Rotator Cuff Disease
1 other identifier
observational
69
1 country
1
Brief Summary
The goal of this observational study is to learn about rotator cuff patients. The main questions it aims to answer are:
- What is the minimal clinically important difference value of the Shoulder Disability Questionnaire, the short version of the Western Ontario Rotator Cuff Index, the Shoulder Rating Questionnaire, and the University of California-Los Angeles Shoulder Scale?
- What is the substantial clinical benefit value of the Shoulder Disability Questionnaire, the short version of the Western Ontario Rotator Cuff Index, the Shoulder Rating Questionnaire, and the University of California-Los Angeles Shoulder Scale?
- What is the patient-acceptable symptomatic state value of the Shoulder Disability Questionnaire, the short version of the Western Ontario Rotator Cuff Index, the Shoulder Rating Questionnaire, and the University of California-Los Angeles Shoulder Scale?
- What is the maximal outcome improvement value of the Shoulder Disability Questionnaire, the short version of the Western Ontario Rotator Cuff Index, the Shoulder Rating Questionnaire, and the University of California-Los Angeles Shoulder Scale?
- What are the risk factors that prevent rotator cuff patients from reaching the minimal clinically important difference value?
- What are the risk factors that prevent rotator cuff patients from reaching the substantial clinical benefit value?
- What are the risk factors that prevent rotator cuff patients from reaching the patient-acceptable symptomatic state value?
- What are the risk factors that prevent rotator cuff patients from reaching the maximal outcome improvement value?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 4, 2024
CompletedFirst Posted
Study publicly available on registry
November 6, 2024
CompletedStudy Start
First participant enrolled
March 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
March 4, 2025
March 1, 2025
1.2 years
November 4, 2024
March 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Functional level
Shoulder Disability Questionnaire (total score between 0-100) (higher values indicate higher disability)
before the treatment and within 1 week after 2 months of treatment
Functional level
The short version of the Western Ontario Rotator Cuff Index (total score between 0-100) (higher values indicate higher functional level)
before the treatment and within 1 week after 2 months of treatment
Functional level
Shoulder Rating Questionnaire (total score between 17-100) (higher values indicate higher functional level)
before the treatment and within 1 week after 2 months of treatment
Functional level
The University of California-Los Angeles Shoulder Scale (total score between 0-100) (higher values indicate higher functional level)
before the treatment and within 1 week after 2 months of treatment
Study Arms (1)
Rotator cuff patients
Patients with rotator cuff disease who will receive conservative treatment.
Interventions
Patients with rotator cuff disease will receive exercise treatment for two months.
Eligibility Criteria
The study will be conducted with rotator cuff patients who will have physical therapy at Kırklareli Training and Research Hospital's physical therapy unit.
You may qualify if:
- to be over 18 years old
- to be a rotator cuff patient
You may not qualify if:
- to have another pathology in the affected shoulder area
- to have a neurological, rheumatological, or oncological disease
- to have radiculopathy
- to have had a previous fracture or operation in the affected shoulder area
- to be not cooperative enough for what will be done within the scope of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kırklareli Eğitim ve Araştırma Hastanesi
Kırklareli, 39000, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ozan Gür, MSc
Kırklareli University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
November 4, 2024
First Posted
November 6, 2024
Study Start
March 3, 2025
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
March 4, 2025
Record last verified: 2025-03